IDEXX Laboratories, Inc. (IDXX) Institutional Ownership & Insider Trading

1,300 institutions reported holding IDEXX Laboratories, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 36 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

IDXXIDEXX Laboratories, Inc.Follow IDXX — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 44.1B
P/E TTM: 39.4
Dividend yield: —
52-week: —
Next earnings: 2 Nov, in 9 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,300 institutions held 94.5% of the shares. Across filers that reported both quarters, shares held changed +1.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,300	74	+1.0%	414	75	440	84
Mar 26	1,303	71	-5.3%	372	80	454	145
Dec 25	1,361	80	+1.5%	414	107	394	55
Sep 25	1,268	73	-1.8%	344	121	412	49
Jun 25	1,209	74	-1.0%	362	151	347	65
Mar 25	1,108	73	+3.3%	400	85	299	66
Dec 24	1,088	72	-3.2%	290	72	379	118
Sep 24	1,084	72	-4.4%	297	69	357	68

IDEXX Laboratories, Inc. — questions

Who owns IDEXX Laboratories, Inc. stock?: 1,300 institutions reported IDEXX Laboratories, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (10.4%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.0%).
Are IDEXX Laboratories, Inc. insiders buying or selling?: 36 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from IDEXX Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.